#
Title
1

Lessons From the Lab: A patient with hand weakness–is a good clinical examination all that you need?

2

AANEM Podcast: Multisystem Proteinopathies

3

Lessons From the Lab: A Patient With Fasciculations Here, There, EVERYWHERE!

4

The Impact of Hormonal Changes During Perimenopause on the Neuromusculoskeletal System - Part 2

5

The Impact of Hormonal Changes During Perimenopause on the Neuromusculoskeletal System - Part 1

6

Monoclonal Gammopathy Associated Myopathies

7

AANEM Crossfire Podcast: Should Neuromuscular Ultrasound be Routinely Used in the Diagnosis of CIDP?

8

Lessons From the Lab: Pediatric EMG Pearls on an Unusual Pediatric Case

9

AANEM Crossfire Podcast: Should Serum Neurofilament Light Chain or NfL be Incorporated into Routine ALS Clinical Practice?

10

AANEM Crossfire Podcast: Should a Combined Sensory Index be Used in Every Case of Suspected Carpal Tunnel Syndrome?

11

Lessons From the Lab: A Numb Foot Could be a Numb-er of Things

12

AANEM Crossfire Podcast: The Balance Between Diagnostic Testing and Clinical Care

13

Lessons From the Lab: LIVE at AANEM – A lively discussion about a strange arm problem.

14

Lessons From the Lab: A woman with shoulder weakness – just a rotator cuff problem?

15

Lessons Learned in the EMG Lab: Elevating EMG Practice Through International Exchange

16

Updates on Neuralgic Amyotrophy

17

Electromyography Referrals Principles and Practices for Optimizing EMG Orders

18

Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies: Part 2

19

Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies - Part 1

20

Lessons From the Lab: Progressive Leg Weakness After Running

21

Postural Orthostatic Tachycardia Syndrome (POTS)

22

Lessons From the Lab: Ulnar Neuropathy

23

Global Standardization of EMG and Nerve Conduction Study Training: Challenges and Collaborative Solutions

24

International Consensus Guidance for the Management of Glucocorticoid Related Complications in Neuromuscular Diseases

25

HMGCR Immune-Mediated Necrotizing Myopathy: Review of Clinical Features and Update on Treatment

26

Lessons From the Lab: Breaking Down Atypical Neuropathy

27

Advancing the Field: Perspectives from Nerve Conduction Technologists

28

Training Program Partnership at AANEM

29

Lessons From the Lab: L5 Radiculopathy

30

Lessons From the Lab: Unilateral Tongue Weakness

31

A Discussion About the ADHERE Study: Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod in Patients With CIDP

32

The Evolving Role of Muscle and Nerve Biopsies in Neuromuscular Diagnosis: A Discussion With Experts

33

Understanding the Safety Factor in Neuromuscular Junction Transmission: A Conversation with Dr. Kyle Mahoney

34

Lessons From the Lab: Patient With Trouble Raising Arm: More Than Rotator Cuff?

35

Building Successful Clinical Trial Programs in Neuromuscular Medicine: Insights from Private Practice Experts

36

Lessons From the Lab: A Patient With Poly Neuropathy & Ulnar Neuropathy

37

CIDP in Focus: Evolving Diagnosis, Treatment, and Future Directions - A Discussion with Global Experts

38

Paraproteinemic Neuropathies

39

Advances in the Therapeutic Landscape of Anti-MAG Neuropathy

40

Clinical and Neurophysiological Recovery of Ulnar Nerve Conduction Block at the Elbow

41

Acquired Hyperexcitable Peripheral Nerve Disorders: Clinical and Laboratory Features, Therapeutic Responses, and Long-Term Follow-Up

42

Lessons From the Lab: LIVE 2 Webinar Recording (Aug. 2024)

43

AANEM EDX Lab Accreditation

44

Promoting Quality EDX in Legislation

45

Lessons From the Lab: Approach to a Patient With Weakness

46

Fraud and Abuse

47

Career Phenotypes Part 4 - Perspective from a Clinician in Private Practice

48

Lessons From the Lab: Clinical, EDX, and Practical Approaches for Progressive Weakness

49

Career Phenotypes Part 3 - Perspectives from Neuromuscular Providers on Subspecialty Selection

50

Career Phenotypes Part 2 - Perspective from a Clinician Researcher

51

Career Phenotypes Part 1 - Perspectives from Clinician Educators in Academic Practice

52

Lessons From the Lab: Navigating EDX with Drs. Rubin and Cartwright

53

Comparison of Muscle Ultrasound and Needle Electromyography Findings in Neuromuscular Disorders

54

The Role of AI in NM and EDX Medicine

55

Lessons From the Lab: Peripheral Neuropathy

56

Lessons From the Lab: LIVE Webinar Recording (March 2024)

57

A Discussion of Three Challenging Electrodiagnostic Cases

58

Lessons From the Lab: Electrodiagnostic Assessment of Polyneuropathy

59

Lessons From the Lab: Subacute Lower Extremity Weakness

60

Lessons From the Lab: Evaluation of Patients With Suspected Motor Neuron Disease

61

Diagnosis and Management of Metabolic Myopathies

62

The Treatment Landscape of Duchenne Muscular Dystrophy, Highlighting Elevidys, the Newly Approved Recombinant Gene Therapy

63

Lessons From the Lab: EMG Discussion with Professor Erik Stalberg

64

Respiratory Considerations in Patients With Neuromuscular Disorders

65

Lessons From the Lab: Scapular Winging

66

ALS Treatment Landscape

67

Lessons From the Lab: A Patient With Bilateral Foot Numbness

68

Lessons From the Lab: EDX & NMUS Approaches to a Patient With Dyspnea

69

Role of Electrodiagnosis in Nerve Transfers for Focal Neuropathies and Brachial Plexopathies

70

Role of Electrodiagnosis in Nerve Transfers for Focal Neuropathies and Brachial Plexopathies

71

Lessons From the Lab: How to Approach Suspected Ulnar Neuropathy in the EMG Laboratory

72

Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

73

Lessons From the Lab: EDX Approach to Radiculopathy

74

Lessons From the Lab

75

Complement and Neonatal Fc Receptor Inhibitors in Myasthenia Gravis, Highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) Trials

76

Complement and Neonatal Fc Receptor Inhibitors in Myasthenia Gravis (MG), Highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials

77

Musculoskeletal Mimics of Cervical Radiculopathy

78

Musculoskeletal Mimics of Cervical Radiculopathy

79

Spinal Muscular Atrophy (SMA) and its Management

80

Spinal Muscular Atrophy and its Management

81

Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis

82

Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis

83

European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force—Second Revision

84

European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force

85

Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

86

Neuromuscular Complications of Immune Checkpoint Inhibitors

87

Neuromuscular Complications of Immune Checkpoint Inhibitors

88

Evaluation of Persons With Suspected Lumbosacral and Cervical Radiculopathy

89

Evaluation of Persons With Suspected Lumbosacral and Cervical Radiculopathy

90

Clinical Features of LRP4/Agrin-Antibody–Positive Myasthenia Gravis

91

Clinical Features of LRP4/agrin-antibody Positive Myasthenia Gravis

92

COVID-19 and Neuromuscular Disorders

93

Approach to Dysphagia With Focus on Neuromuscular Disorders

94

Approach to Dysphagia With Focus on Neuromuscular Disorders

95

Porphyric Neuropathy Part II

96

Porphyric Neuropathy Part I

97

Porphyric Neuropathy Part II

98

Porphyric Neuropathy Part I

99

COVID-19-Associated Guillain-Barre Syndrome: The Early Pandemic Experience

100

COVID-19-Associated Guillain-Barre Syndrome: The Early Pandemic Experience

101

Autonomic Neuropathies

102

Autonomic Neuropathies

103

Guidelines on Clinical Presentation and Management of Nondystrophic Myotonias

104

Guidelines on Clinical Presentation and Management of Nondystrophic Myotonias

105

COVID-19 and Neuromuscular Disorders

106

Electrodiagnostic Approach to Patients Presenting With Respiratory Symptoms

107

Anterior Interosseous Nerve Syndrome

108

Rehabilitative Approach to ALS Patients highlighting Eye-Controlled, Power Wheelchair Performs Well for ALS Patients

109

Immunomodulatory and Immunosuppressive Therapy for Neuromuscular Disorders Part II.

110

Immunomodulatory and Immunosuppressive Therapy for Neuromuscular Disorders Part I

111

Nutritional Neuropathies

112

Quality Improvement Projects in the EMG laboratory

113

Long-term Safety and Efficacy of Eculizumab in Generalized Myasthenia Gravis

114

Ultrasound-Guided Treatment of Peripheral Entrapment Neuropathies

115

Effect of Shoulder and Elbow Position on Ulnar Nerve Conduction

116

Thymectomy may not be Associated With Clinical Improvement in MuSK Myasthenia Gravis

117

Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis

118

Clinical and Electrodiagnostic Features Of Nontraumatic Sciatic Neuropathy

119

Needle Electromyography and Histopathologic Correlation in Myopathies

120

Muscle Biopsy EMG Correlation

121

Long‐Term Neuromuscular Outcomes of West Nile Virus Infection A Clinical and Electromyographic Evaluation of Patients With a History of Infection

122

Electrodiagnostic Errors Contribute to Chronic Inflammatory Demyelinating Polyneuropathy Misdiagnosis

123

Amyloid TTR Treatment Studies

124

Subcutaneous Versus Intravenous Immunoglobulin for Chronic Autoimmune Neuropathies - A Meta-Analysis

125

Complex and Simple Clinical Reaction Times Are Associated with Gait, Balance, and Major Fall Injury

126

Acute Nutritional Axonal Neuropathy

127

The Value Transformation of Health Care: Impact on Neuromuscular and Electrodiagnostic Medicine

128

Hereditary Myopathies With Early Respiratory Insufficiency in Adults

129

Thoracic Outlet Syndrome Part 1 and Part 2

130

Evaluation of Patients With Refractory Chronic Inflammatory Demyelinating Polyneuropathy

131

International Consensus Guidance for Management of Myasthenia Gravis: Executive Summary

132

Optimizing Muscle Selection for Electromyography in Amyotrophic Lateral Sclerosis

133

Association of Inclusion Body Myositis With T Cell Large Granular Lymphocytic Leukaemia

134

Transthyretin Amyloid Neuropathy has Earlier Neural Involvement but Better Prognosis than Primary

135

POEMS vs CIDP

136

Gene Editing in Monogenic Diseases With CRISPR

137

Presymptomatic ALS Genetic Counseling and Testing: Experience and Recommendations

138

Randomized Trial of Thymectomy in Myasthenia Gravis

139

Normative Data Task Force: Establishing High-Quality Reference Values for NCS

140

Rapid Screening for Inflammatory Neuropathies by Standardized Clinical Criteria

141

Sensory Neuronopathies

142

Mutations in SEPT9 Cause Heredic Neuralgic Amyotrophy

143

Critically re-evaluating a common technique: Accuracy, reliability, and confirmation bias of EMG

144

Can Mycophenolate Mofetil be Tapered Safely in MG. A Retrospective, Multicenter Analysis

145

Paraproteinemic Neuropathies

146

Inherited Etiologies of Rhabdomyolysis

147

Pharmacotherapy for Neuropathic Pain in Adults: A Systematic Review and Meta-Analysis

148

Clinical Presentation and Acquired Causes of Rhabdomyolysis

149

Patterns of Clinical and Electrodiagnostic Abnormalities in Early Amyotrophic Lateral Sclerosis

150

NCS technique for ulnar neuropathy

151

NCS Technique for Ulnar Neuropathy

152

Neuralgic Amyotrophy (Parsonage-Turner): Etiology, Treatment, Natural History

153

Neuralgic Amyotrophy (Parsonage-Turner): Presentation & Diagnosis

154

Whole Exome Sequencing

155

Next Generation Sequencing and its Impact on Neuromuscular Medicine

156

ALS Onset is Influenced by the Burden of Rare Variants in Known ALS Genes

157

Muscle Intrusion as a Potential Cause of Carpal Tunnel Syndrome

158

Dermatomyositis and Autoantibodies by Dr. Andrew L. Mammen

159

Necrotizing Myopathies by Dr. Andrew L. Mammen

160

Antisynthetase syndrome and myositis by Dr. Andrew L. Mammen

161

Pathokinesiology of Duchenne Muscular Dystrophy

162

Clinical Value of Motor Nerve Conduction Velocity Determination

163

Diagnosis and Treatment of Limb Girdle and Distal Dystrophies, Evidence-Based Guideline

164

Electrodiagnosis of Ulnar Neuropathy at the Elbow (Une): a Bayesian Approach.

165

Myotonic Dystrophy Health Index: Initial Evaluation of a Disease-Specific Outcome Measure

166

Vasculitic Neuropathies

167

Improving Referring Physicians' Understanding of EMG Reports When Qualifying Radiculopathies

168

Exome Sequencing by Michael Shy, MD and Stephan Zuchner, MD

169

Spinal muscular atrophy: Development and Implementation of Potential Treatments

170

Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead by Dr. Blackhall

171

Myasthenia Gravis and the use of IVIg and Therapeutic Plasma Exchange by Dr. Vern Juel

172

Inherited Neuropathies: Clinical Overview and Update by Drs. Christopher Klein and Michael Shy

173

Electrodiagnosis of ulnar neuropathy at the elbow (Une): A bayesian approach

174

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis by Dr.Steven Greenberg

175

Diagnostic Ultrasound of the Fibular (Peroneal) Nerve by Drs. Francis Walker and Michael Cartwright

176

Diagnostic Ultrasound of the Ulnar Nerve and Ulnar Neuropathy at the Elbow by Drs. Francis Walker and Michael Cartwright

177

Diagnostic Ultrasound of the Median Nerve and Median Neuropathy at the Wrist by Drs. Francis Walker and Michael Cartwright

178

Paraneoplastic Neuromuscular Disorders

179

Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies

180

Chronic pain as a manifestation of potassium channel-complex autoimmunity by Dr. Christopher Klein

181

Diagnosis of the Limb-girdle Muscular Dystrophies by Dr. Kate Bushby

182

The Thoracic Outlet Syndromes

183

The Role of Exercise in Amyotrophic Lateral Sclerosis

184

The Distal Hereditary Motor Neuropathies by Dr. Mary Reilly

185

Myokymic and Neuromyotonic Discharges by Drs. Ludwig Gutmann, Jasper Daube, and Devon Rubin

186

Evidence Based Guideline on Treatment of Painful Diabetic Neuropathy by Vera Bril, MD

187

Cardiomyopathies in Muscular Dystrophies by Christopher Spurney, MD

188

Treatment-induced Diabetic Neuropathy: A Reversible Painful Autonomic Neuropathy

189

ALS may be caused by impaired protein recycling and degradation by Teepu Siddique, MD

190

Good Nutritional Control May Prevent Polyneuropathy After Bariatric Surgery by Pariwat Thaisetthawatkul, MD and P. James Dyck, MD

191

Charcot-Marie-Tooth Disease Subtypes and Genetic Testing Strategies by Michael Shy, MD

192

Evaluation and management of foot drop by John D. Stewart, MBBS,MRCP(UK),FRCP

193

A randomized study of alglucosidase alfa in late-onset Pompe's disease by Robert Leshner, MD, and Paula Clemens, MD

194

Post-surgical Inflammatory Neuropathy by P. James B. Dyck, MD and Nathan Staff, MD

195

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

196

A Novel Autoantibody in Patients with Necrotizing Myopathy by Andrew L. Mammen, MD, PhD

197

Pharmacokinetics of IVIg and Outcome in GBS by Krista Kuitwaard, MD

198

A Practical Approach to the Metabolic Myopathies; Diagnosis and treatment: Glycogen Storage Myopathy

199

Practical Approach to the Metabolic Myopathies: Diagnosis and Treatment-FAOD and Mitochondrial Myopathies by Mark A. Tarnopolsky, MD, PhD

200

Genetics, Pathology, and Treatment of Nondystrophic Myotonias by Michael G. Hanna, MD, and Richard J. Barohn, MD

201

Nondystrophic Myotonias by Michael G. Hanna, MD, and Richard J. Barohn, MD

202

Pulsed High-dose Dexamethasone Versus Standard Prednisolone Treatment for CIDP (PREDICT study): a double-blind, randomized, controlled trial by Ivo N. van Schaik, MD, PhD

203

Influenza Vaccination Safety for Patients with Myasthenia Gravis

204

Inclusion Body Myositis

205

Evaluation and Treatment of the Inflammatory Myopathies

206

Toxic, Including Statin, Myopathies

207

Is There an Increased Risk of GBS Following Influenza Vaccines or Other Vaccines?

208

A Discussion about the Distal Symmetric Polyneuropathy Practice Guidelines by John D. England, MD

209

Ascorbic Acid for Charcot–Marie–Tooth Disease by Joshua Burns, PhD

210

Abnormal EMG Findings During Muscle Activation

211

Abnormal Needle EMG Findings with the Muscle at Rest

212

Needle Electromygraphy

213

Needlestick Injuries Among Electromyographers

214

Risk of Hematoma Following Needle EMG Study in Anticoagulated Patients and Patients on Antiplatelet Therapy

215

Stem Cell Replacement Research for ALS

216

Pediatric Electromyography

217

Myofibrillar Myopathies

218

Lessons Learned in Single Fiber EMG

219

Early Days of Single Fiber EMG

220

IgG1 Antibodies to Acetylcholine Receptors in ‘Seronegative’ MG

221

Limb Girdle Muscular Dystrophy

222

Histopathology of Neuropathy

223

Lifetime Course in Myasthenia Gravis

224

Critical Illness Polyneuropathy and Myopathy

225

Sacral Plexopathies

226

Identifying Lumbosacral Radiculopathies

227

Pathokinesiology of Duchenne Muscular Dystrophy

228

Autosomal-Recessive and X-linked Forms of Hereditary Motor and Sensory Neuropathy in Childhood

229

Immunotherapy in Guillain-Barre Syndrome

230

The Therapy of Congenital Myasthenic Syndromes

231

Safety of Nerve Conduction Studies in Patients with Implanted Cardiac Devices

232

Chronic Inflammatory Polyradiculoneuropathy

233

Electromyographic and Magnetic Resonance Imaging to Predict Lumbar Stenosis, Low-back Pain, and No Back Symptoms by Andrew J. Haig, MD

234

Accuracy of Repetitive Nerve Stimulation for Diagnosis of Cramp-Fasciculation Syndrome

235

An Unusual Variant of Acute Idiopathic Polyneuritis

236

The Influence of the Reference Electrode on CMAP Configuration

237

Uremic Neuropathy: Clinical Features and New Pathophysiologic Insights

238

Experimental Allergic Neuritis

239

Sporadic Onset of Erythermalgia

240

Peripheral Neuropathy in Krabbe Disease

241

Radiculopathy and the Herniated Lumbar Disc

242

Sural Neuropathy: Etiologies and Predisposing Factors

243

Is Exercise Necessary with Repetitive Nerve Stimulation in Evaluating Patients with Suspected Myasthenia Gravis

244

Myelin Protein Zero Mutation His39Pro

245

Interferon-Alpha Beta–Mediated Innate Immune Mechanisms in Dermatomyositis

246

Electrophysiological Findings in a Cohort of Old Polio Survivors

247

Clinical Value of Motor Nerve Conduction Velocity Determination

248

Diabetic and Nondiabetic Lumbosacral Radiculoplexus Neuropathies by P. James B. Dyck, MD

249

Rehabilitation Management of Peripheral Neuropathy

250

The Natural History of Primary Lateral Sclerosis

251

Facioscapulahumeral Muscular Dystrophy by Rabi Tawil, MD

252

Mutations in SEPT9 Cause Heredic Neuralgic Amyotrophy by Phillip Chance, MD and Mark Hannibal, MD

253

Axillary Pain as a Heralding Sign of Neoplasm Involving the Upper Thoracic Root